Ipilimumab: A First-in-Class  T-Cell Potentiator for Metastatic Melanoma

Ipilimumab, a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody that potentiates antitumor T-cell responses, has demonstrated improved survival in previously treated and treatment-naïve patients with unresectable stage III/IV melanoma. Survival benefit has also been shown in dive...

Full description

Saved in:
Bibliographic Details
Main Author: Bartosz Chmielowski
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Skin Cancer
Online Access:http://dx.doi.org/10.1155/2013/423829
Tags: Add Tag
No Tags, Be the first to tag this record!